In humans, the BDNF Val66Met polymorphism, a single nucleotide polymorphism associated with reduced BDNF release, increases the risk of developing PTSD, and is associated with a poorer response to exposure therapy [33, 34]. The gene discussed is BDNF; the disease is post-traumatic stress disorder.